|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.25 TWD | 0.00% |
|
+0.14% | -4.08% |
| 12:54am | Avita Medical's Recell Go Obtains Approval from US FDA | MT |
| 30/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
AViTA Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 255.79 million compared to TWD 287.06 million a year ago. Net income was TWD 24.56 million compared to TWD 23.98 million a year ago.
Basic earnings per share from continuing operations was TWD 0.67 compared to TWD 0.65 a year ago. Diluted earnings per share from continuing operations was TWD 0.67 compared to TWD 0.65 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.08% | 3.98Cr | |
| +75.69% | 1.26TCr | |
| -25.26% | 741.73Cr | |
| +7.63% | 673.81Cr | |
| +12.43% | 533.52Cr | |
| -15.78% | 478.33Cr | |
| +28.18% | 461.75Cr | |
| -21.88% | 368.61Cr | |
| -21.90% | 290.23Cr | |
| +49.20% | 236.85Cr |
AVITA CORPORATION 
